AstraZeneca PLC is 192.9x more valuable than Amylyx Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $1.48 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMLX | AZN |
|---|---|---|
| Market cap | $1.48 B | $286.27 B |
| US-listed rank | #2327 | #45 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$144.74M | - |
| SEC filings | 403 | 1,004 |
AstraZeneca PLC is 192.9x more valuable than Amylyx Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $1.48 B).
Full pages: Amylyx Pharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.